Protalix BioTherapeutics (PLX) Stock Chart & Stock Price History $1.47 -0.07 (-4.55%) As of 07/7/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Protalix BioTherapeutics Stock Price Performance The Protalix BioTherapeutics (PLX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 38.68%, with a year-to-date return of -21.81%. In the past month, the stock has decreased 6.96%, reflecting recent market activity. As of the latest close, Protalix BioTherapeutics traded at $1.47 with a market cap of $117.02 million and volume of 859,387 shares. Receive PLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.85%1 Month Performance-6.96%3 Month Performance-35.53%Year-To-Date Performance-21.81%1 Year Performance+38.68% PLX Stock Chart for Tuesday, July, 8, 2025 PLX Chart by TradingView Protalix BioTherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/07/2025$1.55$1.47-4.85%$1.54$1.46859,387 shs$117.02 million07/04/2025$1.55$1.55$1.55$1.49409,479 shs$122.99 million07/03/2025$1.50$1.55+3.00%$1.55$1.49409,479 shs$122.99 million07/02/2025$1.48$1.50+1.35%$1.52$1.45545,497 shs$119.41 million07/01/2025$1.48$1.48$1.50$1.45380,358 shs$117.82 million06/30/2025$1.54$1.48-3.90%$1.60$1.43997,748 shs$117.82 million06/27/2025$1.45$1.54+6.21%$1.67$1.4212.69 million shs$122.60 million06/26/2025$1.41$1.45+2.84%$1.52$1.41708,182 shs$115.43 million06/25/2025$1.53$1.41-7.84%$1.56$1.41699,006 shs$112.25 million06/24/2025$1.35$1.53+13.33%$1.54$1.35885,839 shs$121.80 million Get the Latest News and Ratings for PLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/23/2025$1.40$1.35-3.57%$1.40$1.32774,917 shs$107.47 million06/20/2025$1.40$1.40$1.44$1.34783,614 shs$111.45 million06/19/2025$1.40$1.40$1.43$1.37402,711 shs$111.45 million06/18/2025$1.37$1.40+2.19%$1.43$1.37402,711 shs$111.45 million06/17/2025$1.43$1.37-4.20%$1.44$1.37644,315 shs$109.06 million06/16/2025$1.49$1.43-4.03%$1.49$1.43690,405 shs$113.84 million06/13/2025$1.54$1.49-3.25%$1.56$1.49500,745 shs$118.61 million06/12/2025$1.57$1.54-1.91%$1.58$1.51455,246 shs$122.60 million06/11/2025$1.58$1.57-0.63%$1.65$1.57479,426 shs$124.98 million06/10/2025$1.54$1.58+2.60%$1.61$1.54497,073 shs$125.78 million06/09/2025$1.58$1.54-2.53%$1.59$1.52611,535 shs$122.60 million Related Companies Mereo BioPharma Group Stock Price Chart Capricor Therapeutics Stock Price Chart Kamada Stock Price Chart Rapport Therapeutics Stock Price Chart Cullinan Therapeutics Stock Price Chart PureTech Health Stock Price Chart MBX Biosciences Stock Price Chart Rezolute Stock Price Chart REGENXBIO Stock Price Chart Tourmaline Bio Stock Price Chart Receive PLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:PLX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protalix BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLX Stock Alerts